March 19, 2016
4 min read
Save

Studies show depressed, anxious patients may not have worse surgical outcomes

Surgeons should not be reluctant to perform spine procedures on anxious patients, based on two studies.

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Depressed and anxious patients who undergo surgery for cervical myelopathy or receive a lumbar epidural steroid injection for degenerative spine disease may experience benefits from these treatments that are similar to those seen in patients who undergo the same procedures but are not depressed, according to investigators.

Perspective from Heidi Prather, DO

Harrison F. Kay, and Silky Chotai, MD, presented two separate studies at the North American Spine Society Annual Meeting that evaluated outcomes of spine procedures in depressed vs. non-depressed patients.

In Kay’s study, the investigators compared outcomes for depressed or anxiety-ridden patients with those of non-depressed patients who underwent surgery for cervical myelopathy.

Harrison F. Kay

“Patients with depression and anxiety have worse absolute pain and disability at 12 months, but similar 12-month change scores and satisfaction following cervical spinal surgery. Patients with psychiatric comorbidities should not be dismissed as potential surgical candidates because they do experience similar benefit from these surgeries,” Kay said.

Kay and colleagues evaluated consecutive patients with cervical myelopathy undergoing operative management. The prospective, registry data-based study included 262 patients who underwent surgery for cervical myelopathy and were followed-up for at least 12 months. Researchers collected baseline and 12-month patient-reported outcome measures (PROMs), Zung Depression Scale (ZDS) and Modified Somatic Perception Questionnaire (MSPQ) scores.

Patients with ZDS scores greater than 33 points were defined as depressed, and patients with MSPQ scores greater than 12 points were defined as anxious.

Kay and colleagues noted that mean 12-month absolute scores for all outcomes were significantly worse in patients who were classified as depressed and/or anxious.

However, the 12-month change scores for Neck Disability Index (NDI) percentage and SF-6D scores for the depressed patients were significantly better than for the non-depressed patients. There were no significant differences in VAS neck and arm pain scores evident between the two groups of patients, according to Kay.

No difference in anxious patients

Kay noted in his presentation that 12-month change scores for NDI percentage were significantly better in anxious patients than non-anxious patients. Also, the differences in VAS neck and arm pain scores between the anxious and non-anxious patients were not significant.

Silky Chotai

The one measure that was significantly different between depressed and non-depressed patients in Kay’s study was satisfaction with surgery. Patients with myelopathy who were depressed had less satisfaction with their surgery compared with non-depressed patients, Kay said.

Similar outcomes for epidurals

Chotai and colleagues evaluated PROMs after lumbar epidural steroid injections for degenerative spine disease in depressed and non-depressed patients.

In findings that were similar to those of Kay and colleagues, the change scores at follow-up were similar between depressed and non-depressed patients, Chotai said in her presentation.

“This suggests patients with underlying depression can expect to receive similar benefits compared to patients who are not depressed. In addition, depressed patients had a significantly higher change or improvement in general health score mental components (SF-12 MCS). Therefore, the studies reporting depression as an indicator for worse outcomes should consider that these patients can achieve as much improvement as non-depressed patients following injection therapy,” she said.

Depression had limited effect

Chotai and colleagues included 161 patients in their study of prospective, longitudinal, registry-based data from a single institution. They included 71 depressed patients and 90 non-depressed patients.

Patients were classified as depressed or non-depressed based on previously validated values for the ZDS. Patients with ZDS scores of less than 33 points were classified as non-depressed, and patients with ZDS scores greater than 33 points were classified as depressed.

The mean absolute patient-reported scores were worse in depressed patients at the 12-month follow-up for Oswestry Disability Index (ODI) percentage scores, EQ-5D scores, SF-12 scores, and back and leg pain scores, according to the investigators.

No effect on change scores

However, there was no statistically significant difference in mean change scores at 12-month follow-up for EQ-5D, SF-12 PCS, ODI percentage, and back and leg pain scores between depressed and non-depressed patients, according to Chotai.

“Although depressed patients had worse baseline and 12-month PROMs, interestingly, the change scores between depressed and non-depressed patients were similar,” she said. – by Robert Linnehan

Disclosures: Chotai and Kay report no relevant financial disclosures.